<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>创鉴汇 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-13T23:37:15+08:00</updated>
  <subtitle>鉴别创新，鉴赏创业。生物医健，全球视野。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>最新融资2.3亿美元，这家公司的“基因书写”技术能否颠覆现有疗法？</title>
    <updated>2021-01-13T21:50:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/yNn0KqiO6a56g0tUIXMmQw</id>
    <link href="https://mp.weixin.qq.com/s/yNn0KqiO6a56g0tUIXMmQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>积极3期临床后又获新一轮投资，TCR疗法能否最终成功？</title>
    <updated>2021-01-12T20:54:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/ZXxVhxUytiwJbWo5WXHk3g</id>
    <link href="https://mp.weixin.qq.com/s/ZXxVhxUytiwJbWo5WXHk3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亘喜生物赴美IPO；再极医药、恒升医疗、新羿生物等获资本青睐 | 大健康产业融资周报</title>
    <updated>2021-01-11T10:39:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/jCUBaaK1p6JuF4mRJCjYIg</id>
    <link href="https://mp.weixin.qq.com/s/jCUBaaK1p6JuF4mRJCjYIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一年内累计融资2.7亿美元，“精准肿瘤治疗2.0”新锐有何不同？</title>
    <updated>2021-01-08T20:01:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Oz03LV2JB9WpNkvcok1q8Q</id>
    <link href="https://mp.weixin.qq.com/s/Oz03LV2JB9WpNkvcok1q8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>获拜耳投资，在细胞疗法中加入“基因回路”，新锐公司完成1.05亿美元B轮融资</title>
    <updated>2021-01-07T23:14:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/bIW-JwWRGY3GHSepVkGKfA</id>
    <link href="https://mp.weixin.qq.com/s/bIW-JwWRGY3GHSepVkGKfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>主攻下一代溶瘤病毒疗法，新锐公司完成7700万美元A轮融资</title>
    <updated>2021-01-06T22:32:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/2UYu2ytJFwJT1l3X1uiELQ</id>
    <link href="https://mp.weixin.qq.com/s/2UYu2ytJFwJT1l3X1uiELQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年生物医药行业有哪些亮点？</title>
    <updated>2021-01-05T20:14:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/oRtZ85qJ3SBv8ik3d0xhPQ</id>
    <link href="https://mp.weixin.qq.com/s/oRtZ85qJ3SBv8ik3d0xhPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>过去一年，蛋白降解剂方向有哪些新的发展趋势？</title>
    <updated>2021-01-04T21:20:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/ByvM7968_zMCtQJAfY450g</id>
    <link href="https://mp.weixin.qq.com/s/ByvM7968_zMCtQJAfY450g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再生细胞疗法IND申请获FDA批准，新锐公司完成新一轮融资，全新疗法能否成功？</title>
    <updated>2020-12-31T17:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/gew4Nt8Aq35nFCGTRa5khA</id>
    <link href="https://mp.weixin.qq.com/s/gew4Nt8Aq35nFCGTRa5khA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新型CAR细胞，癌症早筛，帕金森病疗法…2020年这十个生物医学领域进步瞩目！</title>
    <updated>2020-12-31T17:39:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/ZUa3aQipf8mEL4naUW-mGg</id>
    <link href="https://mp.weixin.qq.com/s/ZUa3aQipf8mEL4naUW-mGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专注个体化癌症疫苗研发，新锐公司完成最新一轮融资</title>
    <updated>2020-12-30T17:29:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/H9IGtEXSyAufMax1LzFqKw</id>
    <link href="https://mp.weixin.qq.com/s/H9IGtEXSyAufMax1LzFqKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>